Cargando…
Usefulness of quantitative analysis of beta-D-glucan in empirical therapy for systematic Candida infection in critically ill patients
Autores principales: | Kano, I, Kamohara, T, Ikegami, K, Taguchi, H, Kawamura, K, Yazawa, J, Mouri, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098179/ http://dx.doi.org/10.1186/cc3092 |
Ejemplares similares
-
Empirical antifungal treatment in the critically ill patients: how does it impact on the outcome?
por: Bruyère, R, et al.
Publicado: (2012) -
Blood transfusions: an independent risk factor for the development of Candida infections in critically ill surgical patients
por: Burghi, G, et al.
Publicado: (2011) -
Safety and efficacy of amphotericin B inhalation for Candida spp. in the respiratory tract of critically ill patients
por: Van der Geest, P, et al.
Publicado: (2014) -
Comparison between mortality and airway colonisation versus noncolonisation with Candida species in critically ill adults
por: Browne, G, et al.
Publicado: (2008) -
Performance of the beta-glucan test and a dynamic prediction rule to identify patients in the ICU at high risk to develop candidemia
por: Nouer, SA, et al.
Publicado: (2015)